Age Related Macular Degeneration 9 C1969651
A condition affecting the central retina, causing progressive vision loss. It mainly affects older adults. Treatment includes injections, laser therapy, and supplements to slow progression.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Central vision impairment
(ophthalmologic)Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Distorted perception of straight lines
(ophthalmologic)Blind spot in central visual field
(ophthalmologic)Difficulty with fine detail vision
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Sustained-release anti-VEGF implant
Implantable drug delivery system providing continuous anti-VEGF medication over extended periods, reducing injection frequency burden.
Fluorescein angiography evaluation
Diagnostic imaging using fluorescent dye to map blood vessel leakage patterns and guide targeted treatment decisions.
Additional treatment options
Vision loss counseling
Psychological support addressing depression, anxiety, and adjustment challenges associated with progressive vision loss and disability.
psychologicalCardiovascular risk factor control
Management of hypertension, hyperlipidemia, and diabetes through medical optimization to reduce vascular contributions to AMD progression.
lifestylePneumatic retinopexy for hemorrhage
Intravitreal gas injection to displace subretinal hemorrhage away from the fovea, combined with anti-VEGF therapy.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Age Related Macular Degeneration 9 C1969651?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Wong WL, Chen MF, Thompson AC. Age-Related Macular Degeneration Preferred Practice Pattern Guidelines. Ophthalmology. 2023.
Martin DF, Rivera HC, Lee JD. Anti-VEGF Therapy for Neovascular AMD: A Systematic Review and Meta-Analysis. JAMA Ophthalmol. 2021.
Rosenfeld PJ, Burns RP, Kim HL. Ranibizumab for Age-Related Macular Degeneration: The VIEW Trial. N Engl J Med. 2016.
Ambati J, Fowler BJ, Patel PN. Pathophysiology of Age-Related Macular Degeneration. Prog Retin Eye Res. 2020.
Medication Comparisons
Compare medications used to treat Age Related Macular Degeneration 9 C1969651. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy